![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: PPM1B |
Gene summary for PPM1B |
![]() |
Gene information | Species | Human | Gene symbol | PPM1B | Gene ID | 5495 |
Gene name | protein phosphatase, Mg2+/Mn2+ dependent 1B | |
Gene Alias | PP2C-beta | |
Cytomap | 2p21 | |
Gene Type | protein-coding | GO ID | GO:0001816 | UniProtAcc | O75688 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
5495 | PPM1B | LZE4T | Human | Esophagus | ESCC | 1.45e-09 | 3.16e-01 | 0.0811 |
5495 | PPM1B | LZE7T | Human | Esophagus | ESCC | 3.13e-03 | 3.97e-01 | 0.0667 |
5495 | PPM1B | LZE8T | Human | Esophagus | ESCC | 1.65e-02 | -3.37e-02 | 0.067 |
5495 | PPM1B | LZE20T | Human | Esophagus | ESCC | 5.64e-08 | 1.98e-02 | 0.0662 |
5495 | PPM1B | LZE24T | Human | Esophagus | ESCC | 2.30e-17 | 4.57e-01 | 0.0596 |
5495 | PPM1B | LZE21T | Human | Esophagus | ESCC | 4.04e-07 | 3.42e-01 | 0.0655 |
5495 | PPM1B | P1T-E | Human | Esophagus | ESCC | 1.82e-12 | 4.33e-01 | 0.0875 |
5495 | PPM1B | P2T-E | Human | Esophagus | ESCC | 4.31e-36 | 6.57e-01 | 0.1177 |
5495 | PPM1B | P4T-E | Human | Esophagus | ESCC | 2.38e-17 | 5.52e-01 | 0.1323 |
5495 | PPM1B | P5T-E | Human | Esophagus | ESCC | 2.40e-23 | 3.16e-01 | 0.1327 |
5495 | PPM1B | P8T-E | Human | Esophagus | ESCC | 5.28e-17 | 2.64e-01 | 0.0889 |
5495 | PPM1B | P9T-E | Human | Esophagus | ESCC | 1.66e-27 | 3.28e-01 | 0.1131 |
5495 | PPM1B | P10T-E | Human | Esophagus | ESCC | 4.82e-23 | 3.90e-01 | 0.116 |
5495 | PPM1B | P11T-E | Human | Esophagus | ESCC | 1.58e-13 | 6.31e-01 | 0.1426 |
5495 | PPM1B | P12T-E | Human | Esophagus | ESCC | 8.21e-38 | 6.54e-01 | 0.1122 |
5495 | PPM1B | P15T-E | Human | Esophagus | ESCC | 1.49e-24 | 6.71e-01 | 0.1149 |
5495 | PPM1B | P16T-E | Human | Esophagus | ESCC | 1.11e-31 | 4.49e-01 | 0.1153 |
5495 | PPM1B | P19T-E | Human | Esophagus | ESCC | 3.16e-10 | 3.24e-01 | 0.1662 |
5495 | PPM1B | P20T-E | Human | Esophagus | ESCC | 1.49e-13 | 2.34e-01 | 0.1124 |
5495 | PPM1B | P21T-E | Human | Esophagus | ESCC | 4.25e-18 | 1.37e-01 | 0.1617 |
Page: 1 2 3 4 5 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:000961518 | Esophagus | ESCC | response to virus | 238/8552 | 367/18723 | 6.65e-14 | 3.32e-12 | 238 |
GO:004354313 | Esophagus | ESCC | protein acylation | 165/8552 | 243/18723 | 1.69e-12 | 7.14e-11 | 165 |
GO:0043122110 | Esophagus | ESCC | regulation of I-kappaB kinase/NF-kappaB signaling | 167/8552 | 249/18723 | 6.11e-12 | 2.32e-10 | 167 |
GO:000724919 | Esophagus | ESCC | I-kappaB kinase/NF-kappaB signaling | 183/8552 | 281/18723 | 3.02e-11 | 1.01e-09 | 183 |
GO:001605517 | Esophagus | ESCC | Wnt signaling pathway | 268/8552 | 444/18723 | 2.32e-10 | 6.58e-09 | 268 |
GO:019873817 | Esophagus | ESCC | cell-cell signaling by wnt | 269/8552 | 446/18723 | 2.41e-10 | 6.79e-09 | 269 |
GO:00516075 | Esophagus | ESCC | defense response to virus | 171/8552 | 265/18723 | 3.91e-10 | 1.05e-08 | 171 |
GO:01405465 | Esophagus | ESCC | defense response to symbiont | 171/8552 | 265/18723 | 3.91e-10 | 1.05e-08 | 171 |
GO:001631110 | Esophagus | ESCC | dephosphorylation | 251/8552 | 417/18723 | 1.26e-09 | 2.99e-08 | 251 |
GO:000647018 | Esophagus | ESCC | protein dephosphorylation | 177/8552 | 281/18723 | 3.13e-09 | 6.72e-08 | 177 |
GO:003011117 | Esophagus | ESCC | regulation of Wnt signaling pathway | 194/8552 | 328/18723 | 5.39e-07 | 7.14e-06 | 194 |
GO:006007016 | Esophagus | ESCC | canonical Wnt signaling pathway | 180/8552 | 303/18723 | 9.15e-07 | 1.17e-05 | 180 |
GO:006082817 | Esophagus | ESCC | regulation of canonical Wnt signaling pathway | 153/8552 | 253/18723 | 1.38e-06 | 1.67e-05 | 153 |
GO:00028318 | Esophagus | ESCC | regulation of response to biotic stimulus | 191/8552 | 327/18723 | 2.12e-06 | 2.45e-05 | 191 |
GO:000283212 | Esophagus | ESCC | negative regulation of response to biotic stimulus | 72/8552 | 108/18723 | 8.36e-06 | 8.11e-05 | 72 |
GO:00421573 | Esophagus | ESCC | lipoprotein metabolic process | 86/8552 | 135/18723 | 1.78e-05 | 1.57e-04 | 86 |
GO:00064973 | Esophagus | ESCC | protein lipidation | 62/8552 | 92/18723 | 2.08e-05 | 1.80e-04 | 62 |
GO:00421583 | Esophagus | ESCC | lipoprotein biosynthetic process | 64/8552 | 96/18723 | 2.61e-05 | 2.20e-04 | 64 |
GO:009026316 | Esophagus | ESCC | positive regulation of canonical Wnt signaling pathway | 69/8552 | 106/18723 | 4.22e-05 | 3.39e-04 | 69 |
GO:003017716 | Esophagus | ESCC | positive regulation of Wnt signaling pathway | 87/8552 | 140/18723 | 6.18e-05 | 4.73e-04 | 87 |
Page: 1 2 3 4 5 6 7 8 9 10 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa0401014 | Oral cavity | OSCC | MAPK signaling pathway | 165/3704 | 302/8465 | 7.11e-05 | 2.74e-04 | 1.40e-04 | 165 |
hsa0401015 | Oral cavity | OSCC | MAPK signaling pathway | 165/3704 | 302/8465 | 7.11e-05 | 2.74e-04 | 1.40e-04 | 165 |
hsa0401023 | Oral cavity | EOLP | MAPK signaling pathway | 68/1218 | 302/8465 | 7.48e-05 | 3.40e-04 | 2.01e-04 | 68 |
hsa0401033 | Oral cavity | EOLP | MAPK signaling pathway | 68/1218 | 302/8465 | 7.48e-05 | 3.40e-04 | 2.01e-04 | 68 |
hsa0401041 | Oral cavity | NEOLP | MAPK signaling pathway | 59/1112 | 302/8465 | 9.40e-04 | 4.67e-03 | 2.94e-03 | 59 |
hsa0401051 | Oral cavity | NEOLP | MAPK signaling pathway | 59/1112 | 302/8465 | 9.40e-04 | 4.67e-03 | 2.94e-03 | 59 |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
PPM1B | insertion | Frame_Shift_Ins | novel | c.1226_1227insAGTAATAT | p.Leu410ValfsTer9 | p.L410Vfs*9 | O75688 | protein_coding | TCGA-BR-8485-01 | Stomach | stomach adenocarcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD | ||
PPM1B | deletion | Frame_Shift_Del | novel | c.168delT | p.Phe56LeufsTer21 | p.F56Lfs*21 | O75688 | protein_coding | TCGA-CD-A4MG-01 | Stomach | stomach adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | PD | ||
PPM1B | deletion | Frame_Shift_Del | novel | c.168delT | p.Phe56LeufsTer21 | p.F56Lfs*21 | O75688 | protein_coding | TCGA-CG-5723-01 | Stomach | stomach adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | ||
PPM1B | SNV | Missense_Mutation | novel | c.1225N>A | p.Gln409Lys | p.Q409K | O75688 | protein_coding | tolerated_low_confidence(0.49) | benign(0.018) | TCGA-ET-A40S-01 | Thyroid | thyroid carcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
PPM1B | insertion | In_Frame_Ins | novel | c.762_763insCTTTTCCCT | p.Leu254_Cys255insLeuPhePro | p.L254_C255insLFP | O75688 | protein_coding | TCGA-EL-A3ZG-01 | Thyroid | thyroid carcinoma | Male | <65 | I/II | Unknown | Unknown | SD | ||
PPM1B | insertion | In_Frame_Ins | novel | c.175_176insTGGGTTTATCCAAAA | p.Tyr59delinsLeuGlyLeuSerLysAsn | p.Y59delinsLGLSKN | O75688 | protein_coding | TCGA-EL-A3ZN-01 | Thyroid | thyroid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | ||
PPM1B | insertion | Frame_Shift_Ins | novel | c.175_176insTGGGTTTATCCAAAAATGCACCC | p.Tyr59LeufsTer26 | p.Y59Lfs*26 | O75688 | protein_coding | TCGA-EL-A3ZP-01 | Thyroid | thyroid carcinoma | Male | <65 | I/II | Unknown | Unknown | SD | ||
PPM1B | insertion | Frame_Shift_Ins | novel | c.1226_1227insAGTAATAT | p.Leu410ValfsTer9 | p.L410Vfs*9 | O75688 | protein_coding | TCGA-ET-A40S-01 | Thyroid | thyroid carcinoma | Male | <65 | I/II | Unknown | Unknown | SD | ||
PPM1B | insertion | Nonsense_Mutation | novel | c.1217_1218insGTAATATAGT | p.Asn406LysfsTer2 | p.N406Kfs*2 | O75688 | protein_coding | TCGA-FY-A40L-01 | Thyroid | thyroid carcinoma | Female | <65 | I/II | Hormone Therapy | levothyroxine | SD | ||
PPM1B | insertion | Nonsense_Mutation | novel | c.1219_1220insAAGC | p.Tyr407Ter | p.Y407* | O75688 | protein_coding | TCGA-FY-A40L-01 | Thyroid | thyroid carcinoma | Female | <65 | I/II | Hormone Therapy | levothyroxine | SD |
Page: 1 2 3 4 5 6 7 8 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |